Biotricity (BTCY) Competitors $0.60 -0.07 (-9.94%) As of 03:15 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock BTCY vs. CTCX, PYPD, MDAI, DXR, SRTS, EDAP, ZYXI, APT, SURG, and GUTSShould you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Carmell (CTCX), PolyPid (PYPD), Spectral AI (MDAI), Daxor (DXR), Sensus Healthcare (SRTS), EDAP TMS (EDAP), Zynex (ZYXI), Alpha Pro Tech (APT), SurgePays (SURG), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. Biotricity vs. Its Competitors Carmell PolyPid Spectral AI Daxor Sensus Healthcare EDAP TMS Zynex Alpha Pro Tech SurgePays Fractyl Health Biotricity (NASDAQ:BTCY) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation. Is BTCY or CTCX more profitable? Carmell has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets Biotricity-80.42% N/A -188.47% Carmell N/A -217.50%-50.22% Does the media favor BTCY or CTCX? In the previous week, Biotricity had 1 more articles in the media than Carmell. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for Carmell. Carmell's average media sentiment score of 0.67 beat Biotricity's score of 0.00 indicating that Carmell is being referred to more favorably in the news media. Company Overall Sentiment Biotricity Neutral Carmell Positive Which has stronger earnings & valuation, BTCY or CTCX? Biotricity has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiotricity$12.06M1.25-$14.09M-$0.21-2.87Carmell$32.84K1,502.35-$15.44MN/AN/A Do analysts rate BTCY or CTCX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, BTCY or CTCX? Biotricity has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Do institutionals and insiders hold more shares of BTCY or CTCX? 3.9% of Biotricity shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 10.1% of Biotricity shares are owned by company insiders. Comparatively, 29.0% of Carmell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryBiotricity and Carmell tied by winning 6 of the 12 factors compared between the two stocks. Get Biotricity News Delivered to You Automatically Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTCY vs. The Competition Export to ExcelMetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.02M$81.72M$5.75B$9.85BDividend YieldN/AN/A6.67%4.51%P/E Ratio-0.5612.1278.4326.42Price / Sales1.2597.89546.94119.09Price / CashN/A18.4137.0558.92Price / Book-0.469.1210.916.06Net Income-$14.09M-$26.48M$3.29B$266.28M7 Day Performance5.81%0.33%0.01%-0.76%1 Month Performance67.53%8.23%7.06%3.83%1 Year Performance54.25%77.81%50.09%24.39% Biotricity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTCYBiotricityN/A$0.60-9.9%N/A+63.3%$15.02M$12.06M-0.5640News CoverageGap DownCTCXCarmellN/A$2.70+3.6%N/A+416.1%$56.44M$32.84K0.0014PYPDPolyPid2.5551 of 5 stars$3.42-0.9%$12.40+262.6%-3.7%$54.85MN/A-0.8980Short Interest ↑MDAISpectral AI2.6695 of 5 stars$2.05+1.0%$3.50+70.7%+28.8%$54.26M$29.58M-2.9783DXRDaxor3.6936 of 5 stars$10.85-1.4%$25.00+130.4%+22.2%$52.48MN/A0.0037News CoveragePositive NewsShort Interest ↑SRTSSensus Healthcare1.814 of 5 stars$3.29+5.1%$8.00+143.2%-48.3%$51.46M$41.81M-54.8340Gap DownEDAPEDAP TMS2.5304 of 5 stars$1.53+11.7%$8.50+455.6%-21.2%$51.23M$69.18M-2.47230News CoverageShort Interest ↑Analyst RevisionZYXIZynex1.8115 of 5 stars$1.66-1.2%$4.90+195.2%-81.1%$50.90M$192.35M-1.77770APTAlpha Pro Tech1.8803 of 5 stars$4.86-0.6%N/A-17.0%$50.90M$58.56M13.14120Short Interest ↓SURGSurgePays2.6134 of 5 stars$2.49flat$9.00+261.4%+94.4%$50.88M$36.46M-1.0040Short Interest ↑GUTSFractyl Health2.3044 of 5 stars$1.01+1.0%$8.00+692.1%-72.0%$50.29M$90K-0.49102News Coverage Related Companies and Tools Related Companies Carmell Alternatives PolyPid Alternatives Spectral AI Alternatives Daxor Alternatives Sensus Healthcare Alternatives EDAP TMS Alternatives Zynex Alternatives Alpha Pro Tech Alternatives SurgePays Alternatives Fractyl Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTCY) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
